Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-09 Sale | 2024-12-11 4:28 pm | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 13,664 | $25.26 | $345,134 | 212,132 (Direct) | View |
| 2024-11-19 Sale | 2024-11-21 6:52 pm | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 38,689 | $16.78 | $649,030 | 400,600 (Direct) | View |
| 2024-11-14 Purchase | 2024-11-18 7:35 pm | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 431,940 | $17.07 | $7,373,527 | 9,316,199 (Indirect Direct) | View |
| 2024-11-14 Sale | 2024-11-18 7:32 pm | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 82,368 | $17.46 | $1,438,038 | 536,257 (Direct) | View |
| 2024-11-14 Sale | 2024-11-18 7:28 pm | Cartesian Therapeutics Inc. | RNAC | Miljkovic Milos Chief Medical Officer | 55,000 | $16.5 | $907,533 | 99,329 (Direct) | View |
| 2024-11-14 Sale | 2024-11-18 7:23 pm | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 52,115 | $16.79 | $875,042 | 222,869 (Direct) | View |
| 2024-10-02 Purchase | 2024-10-04 5:58 pm | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 205,721 | $20.87 | $4,293,545 | 12,759,887 (Indirect Direct) | View |
| 2024-08-12 Purchase | 2024-08-14 4:43 pm | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 8,016 | $12.72 | $101,968 | 6,319,038 (Indirect Direct) | View |
| 2024-08-12 Purchase | 2024-08-14 4:41 pm | Cartesian Therapeutics Inc. | RNAC | BARABE TIMOTHY C Director | 7,500 | $12.7 | $95,250 | 29,366 (Direct) | View |
| 2024-01-17 Purchase | 2024-03-28 5:11 pm | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 18,400 | $0.62186 | $11,442 | 40,620,292 (Indirect Direct) | View |
| 2024-03-18 Purchase | 2024-03-20 5:09 pm | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 19,044 | $0.5985 | $11,398 | 38,631,449 (Indirect Direct) | View |
| 2024-03-14 Purchase | 2024-03-18 5:29 pm | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 1,185,872 | $0.5618 | $666,222 | 38,612,405 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-09 Exercise | 2024-12-11 4:28 pm | N/A 2026-11-06 | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 13,664 | $0 | 212,132 (Direct) | View |
| 2024-12-09 Exercise | 2024-12-11 4:28 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 13,664 | $1.41 | 212,132 (Direct) | View |
| 2024-11-19 Exercise | 2024-11-21 6:52 pm | N/A 2026-11-06 | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 38,689 | $0 | 400,600 (Direct) | View |
| 2024-11-19 Exercise | 2024-11-21 6:52 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 38,689 | $1.41 | 400,600 (Direct) | View |
| 2024-11-19 Gift | 2024-11-21 6:51 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Singer Michael Director | 28,821 | $0 | 745,801 (Direct) | View |
| 2024-11-20 Exercise | 2024-11-21 6:50 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 14,000 | $3.23 | 116,372 (Direct) | View |
| 2024-11-20 Exercise | 2024-11-21 6:50 pm | N/A 2033-01-15 | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 14,000 | $0 | 116,372 (Direct) | View |
| 2024-11-14 Exercise | 2024-11-18 7:32 pm | N/A 2026-11-06 | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 82,368 | $0 | 536,257 (Direct) | View |
| 2024-11-14 Exercise | 2024-11-18 7:32 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 82,368 | $1.41 | 536,257 (Direct) | View |
| 2024-11-14 Exercise | 2024-11-18 7:28 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Miljkovic Milos Chief Medical Officer | 55,000 | $3.23 | 99,329 (Direct) | View |
| 2024-11-14 Exercise | 2024-11-18 7:28 pm | N/A 2031-09-12 | Cartesian Therapeutics Inc. | RNAC | Miljkovic Milos Chief Medical Officer | 55,000 | $0 | 99,329 (Direct) | View |
| 2024-11-14 Exercise | 2024-11-18 7:23 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 52,115 | $3.23 | 222,869 (Direct) | View |
| 2024-11-14 Exercise | 2024-11-18 7:23 pm | N/A 2033-01-15 | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 52,115 | $0 | 222,869 (Direct) | View |
| 2024-10-11 Exercise | 2024-10-15 4:53 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Kalayoglu Murat Director 10% Owner | 1,563,924 | $0 | 5,118,039 (Indirect) | View |
| 2024-10-11 Exercise | 2024-10-15 4:43 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Hoge Elizabeth Seven One Eight Three Four Irrevocable Trust 10% Owner | 1,563,924 | $0 | 5,118,039 (Indirect) | View |
| 2024-10-02 Other | 2024-10-04 5:58 pm | 2022-04-11 2027-04-11 | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 4,505,650 | $0 | 12,759,887 (Indirect) | View |
| 2024-09-25 Exercise | 2024-09-27 4:13 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 2,359,500 | $0 | 6,029,547 (Direct) | View |
| 2024-07-02 Option Award | 2024-07-05 4:02 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 2,359,500 | $20 | 7,949,161 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 4:10 pm | N/A 2034-06-30 | Cartesian Therapeutics Inc. | RNAC | Malik Kemal Director | 13,533 | $0 | 13,533 (Direct) | View |
Ownership | 2024-04-19 4:49 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | English Emily SVP, Head of Manufacturing | 0 | $0 | 112,979 (Direct) | View |
| 2024-04-08 Exercise | 2024-04-10 9:47 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Singer Michael Director | 681,827 | $0 | 223,573 (Direct) | View |
| 2024-04-08 Exercise | 2024-04-10 9:43 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Kalayoglu Murat Director 10% Owner | 3,521,176 | $0 | 3,652,817 (Direct) | View |
| 2024-04-08 Exercise | 2024-04-10 9:40 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 5,105,725 | $0 | 6,485,662 (Direct) | View |
| 2024-04-08 Exercise | 2024-04-10 9:35 pm | N/A 2033-01-15 | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 146,823 | $0 | 201,752 (Direct) | View |
| 2024-04-08 Exercise | 2024-04-10 9:33 pm | N/A 2031-09-12 | Cartesian Therapeutics Inc. | RNAC | Miljkovic Milos Chief Medical Officer | 88,094 | $0 | 127,234 (Direct) | View |
| 2024-04-08 Exercise | 2024-04-10 9:30 pm | N/A 2026-11-06 | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 249,598 | $0 | 358,860 (Direct) | View |
| 2024-04-08 Conversion | 2024-04-10 4:20 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Hoge Elizabeth Seven One Eight Three Four Irrevocable Trust 10% Owner | 3,521,176 | $0 | 608,330 (Indirect) | View |
| 2024-03-26 Exercise | 2024-03-26 4:32 pm | 2019-12-23 2024-12-23 | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 1,970,443 | $0 | 40,601,892 (Indirect) | View |
| 2024-03-26 Exercise | 2024-03-26 4:32 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 1,970,443 | $1.46 | 40,601,892 (Indirect) | View |
| 2023-12-22 Gift | 2024-01-04 5:12 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Singer Michael Director 10% Owner | 3,000 | $0 | 882,312 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 5:12 pm | N/A 2034-01-01 | Cartesian Therapeutics Inc. | RNAC | Singer Michael Director 10% Owner | 406,000 | $0 | 882,312 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 5:08 pm | N/A 2034-01-01 | Cartesian Therapeutics Inc. | RNAC | Davis Blaine Chief Financial Officer | 5,534,000 | $0 | 5,534,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 5:08 pm | N/A 2034-01-01 | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 1,776,200 | $0 | 1,776,200 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 5:07 pm | N/A 2034-01-01 | Cartesian Therapeutics Inc. | RNAC | Brunn Carsten President and CEO | 10,625,100 | $0 | 10,887,056 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 5:07 pm | N/A 2034-01-01 | Cartesian Therapeutics Inc. | RNAC | Sallin Aymeric Director | 406,000 | $0 | 406,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 5:06 pm | N/A 2034-01-01 | Cartesian Therapeutics Inc. | RNAC | BARABE TIMOTHY C Director | 406,000 | $0 | 656,013 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 5:06 pm | N/A 2034-01-01 | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 406,000 | $0 | 37,654,533 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 5:06 pm | N/A 2034-01-01 | Cartesian Therapeutics Inc. | RNAC | Miljkovic Milos Chief Medical Officer | 1,251,200 | $0 | 1,251,200 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 5:05 pm | N/A 2034-01-01 | Cartesian Therapeutics Inc. | RNAC | DeSilva Nishan M Director | 406,000 | $0 | 413,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 5:05 pm | N/A 2034-01-01 | Cartesian Therapeutics Inc. | RNAC | COX CARRIE SMITH Director | 426,000 | $0 | 638,881 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 5:04 pm | N/A 2034-01-01 | Cartesian Therapeutics Inc. | RNAC | ZENNER PATRICK J Director | 406,000 | $0 | 461,248 (Direct) | View |